Locations

Clinical Studies

Alzheimer’s Disease & Memory Loss

Alzheimer's disease is a progressive neurological disorder and the most common cause of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life.

The symptoms of Alzheimer's disease progress in stages, typically beginning with mild short-term memory loss and difficulty with new information. As the disease advances, individuals experience worsening confusion, disorientation, difficulty with language, and impaired judgment, leading to increasing trouble with familiar tasks like driving, managing finances, or carrying on a conversation.

We’re partnering with patients like you on groundbreaking research to help doctors and caregivers treat and care for those affected by Alzheimer’s disease today, as well as those who come after us.

We encourage you to fill out the form on this page to learn more about Alzheimer's disease clinical studies.

Charter Research also offers Free Memory Screens.

Get More Information

This field is for validation purposes and should be left unchanged.

Your contact information

Newsletter
Consent

Types of Studies

What studies are available?

Here you’ll find the clinical trials that we’re currently enrolling patients in or will be soon.

View All Open Studies

Alzheimer’s Biomarker Study
Imagine your body is like a car, and you want to know how it's running. A biomarker is like a gauge or a warning light on the dashboard, something measurable that may indicate if you have a disease, how well a treatment is working, or if you're at risk for a future health problem.
Alzheimer’s End-Of-Life Study
The purpose of this end-of-life study is to evaluate the effectiveness of a new brain (PET) scan in accurately detecting Alzheimer’s disease. We hope that earlier, more accurate detection of Alzheimer’s disease will one day allow patients to confirm their diagnosis more easily, and then they can confidently begin new treatments that may delay—or eventually even reverse—the progression of the disease.
Alzheimer’s Cortisol Study
The investigational drug was developed in response to evidence of a strong association between chronically-raised cortisol levels and the development of cognitive impairment in Alzheimer’s disease. The drug is designed to target and block production of cortisol inside brain neurons.
Early Alzheimer’s Study
The purpose of this early Alzheimer's study is to find out if the study drug can possibly prevent, delay, or slow early symptoms of Alzheimer’s disease.
Alzheimer’s Agitation Study
Agitation in all its forms—from finger tapping, nail biting and restlessness to excessive motor activity, verbal aggression, or even physical aggression—is particularly challenging because there are currently no effective treatments for it.
Free Memory Screen
A memory screen is a brief, simple test used to evaluate a person's memory and other cognitive functions, like language skills and thinking ability.

Our Promise to You

What resources do you have for me?

We regularly share insights, tips, and new discoveries to provide you the latest on the diseases and chronic conditions you’re living with.

See all resources

Can You Reverse Mild Cognitive Impairment?
Nearly one in five Americans over the age of 60 experience subtle downturns in memory, thinking, and cognition. Clinically, this fading of cognitive abilities is...
Learn more about Can You Reverse Mild Cognitive Impairment?
The lesser-known problematic protein wreaking havoc on the brain: TDP-43
Scientists have linked the progression of Alzheimer’s to the buildup of certain kinds of protein in the brain. Sometimes, these proteins malfunction and gum up...
Learn more about The lesser-known problematic protein wreaking havoc on the brain: TDP-43
Could Drugs for Other Diseases Be the Answer to Treating Alzheimer’s?
Asthma drugs, cancer drugs, even obesity drugs, are all being explored for their potential in treating the pathology and symptoms of Alzheimer’s disease. Finding the...
Learn more about Could Drugs for Other Diseases Be the Answer to Treating Alzheimer’s?
Why Women Are More Likely to Develop Alzheimer’s
Research has established that women are twice as likely to develop Alzheimer’s, but—despite study after study into this sex-based disparity in Alzheimer’s risk—scientists are still...
Learn more about Why Women Are More Likely to Develop Alzheimer’s
Managing Symptoms in the Later Stages of Alzheimer’s
Symptom management in Alzheimer’s helps people remain independent for longer. Alzheimer’s disease is a progressive neurodegenerative condition that affects more than one in every 9...
Learn more about Managing Symptoms in the Later Stages of Alzheimer’s
A Pill For Alzheimer’s? Alzheon Starts Clinical Trials
Charter Research is recruiting for a new Phase 3 trial for Alzheon’s new drug, which aims to be the first oral disease-modifying therapy for Alzheimer’s....
Learn more about A Pill For Alzheimer’s? Alzheon Starts Clinical Trials